Never before has in vitro diagnostics been so crucial. Tests for cancer and infectious disease detection, transplant success, pharmaceutical selection have added healthcare value and improved outcomes. Genetic tests for rare diseases and prenatal assessment are increasingly utilized. And now, the COVID-19 pandemic has highlighted how important testing is in a way that could not be imagined.
But in vitro diagnostics represents a large market, with scores of significant competitors. Sorting out the marketplace can be difficult without a definitive guide. What is the market size for clinical chemistry, immunoassays, molecular tests, hematology tests and other test categories? Who’s winning? Who’s launched game-changing products?
Now in its 13th edition, this Kalorama Information report, The Worldwide Market for In Vitro Diagnostic (IVD) Tests, is the most essential report on the IVD industry. For two decades, the 1,500-plus page report has provided reliable estimates and real-world forecasts for the in vitro diagnostics industry.
As part of its offering, this report includes:
COVID-19 Impact on Markets, and COVID-19 Test Markets
1500 + Page Report Based on Vendor Reporting, Interviews, Vendor Activities
Authored by Veteran IVD Analysts with Industry Knowledge
12 Detailed Market Chapters with 2020 Market Estimates
Where is IVD Heading? – Market Segment Projections to 2025
Regional Breakouts Including Country IVD Markets
Sections on China and The United States IVD Markets
Coverage of Growth Markets: Eastern Europe and the Middle East, and Southeast Asia
Superior Company Profiles of Top Tier Companies and Hundreds of Smaller Concerns
Industry-Standard Business Planning Tools
Coverage of Trends and Market Estimates for Essential IVD Segments:
- Clinical Chemistry
- Infectious Disease
- Blood Banking
- Microbiology, ID/AST
- Microbiology, Pathogen Detection
- Immunoassays, All Types
- Histology and More
The Worldwide Market for In Vitro Diagnostic (IVD) Tests estimates the current in vitro diagnostics market size and forecasted market size to 2025 for defined segments of the IVD market and various sub-segments, including:
COVID Testing – Immunoassays and Molecular
Molecular Assays (Infectious Disease, Blood Screening, Inherited Diseases, Oncology, PGx, Tissue Typing, Prenatal)
Clinical Chemistry and “Core Lab” Markets
Point-of-Care Testing (POC) (Professional and Self-Testing
Substance Abuse Testing
Microbiology and Virology by Test Type (Immunoassays, ID/AST, Infectious Diseases – DNA; ID/AST: Panels and Reagents, automated; Panels and Reagents, manual; Blood Culture; Chromogenic Media; Rapid Micro; Supplies)
Pap, ISH, IHC, HPV and Other Tissue-Based Tests
Infectious Disease Immunoassay Testing
Cardiac Markers, Tumor Markers, Diabetes/hbA1c, Autoimmune, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic Drugs
For each of the listed in vitro diagnostics market segments, 2019 in vitro diagnostics market size, 2025 projection and compound annual growth rate is provided, as well as significant in vitro diagnostic companies in the market and IVD manufacturers’ product innovations. The market data is put into a context with real-world industry and medical practice trends.
The Worldwide Market for In Vitro Diagnostic Tests has been called “The Bible of the IVD Industry” by customers, which include top IVD firms. Using Kalorama Information’s The Worldwide Market for In vitro Diagnostic (IVD) Tests, 13th Edition, ensures that your firm will have the perspective and data of others in the in vitro diagnostics industry, as well as of those who track and invest in the IVD industry.
Global Coverage for a Global Industry
The in vitro diagnostics market is a global one, and The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 13th Edition reflects the international scope of the in vitro diagnostics market size. In the healthcare market, IVD companies sell globally and think globally. Trends in one part of the world affect IVD manufacturers’ product decisions and company financial performance in others. Thus, this is a global report, and the following regional and country overall IVD markets are included:
- Saudi Arabia
- Eastern Europe
- Emerging Markets
- Rest of World
The Worldwide Market for In Vitro Diagnostic Tests is a testament to the Kalorama methodology. It is the result of months of painstaking work by an experienced IVD industry analyst, who has tracked hundreds of in vitro diagnostic companies for developments, trends and financial results. This research is compiled along with the opinion, observations and insights of industry experts to produce an unparalleled vision of the in vitro diagnostics industry as it is in 2020.
Who’s In The Market? Who’s Winning?
The report concentrates over a thousand pages on detailed and tiered profiles of companies in the in vitro diagnostics market. The experience that Kalorama Information has in the in vitro diagnostic market is evident in its tiering and segmentation of companies. First tier, second-tier and specialist companies are profiled. Financial results, product launches, company history and strategic plans are analyzed in the profiles. Over 200 Profiles are included in the report.